RECRUITING

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Description

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Study Overview

Study Details

Study overview

This study aims to evaluate the efficacy of deep transcranial magnetic stimulation (dTMS) as a treatment for Veterans with a methamphetamine use disorder (MUD).

Deep TMS Neuromodulation of Neural Circuits Associated With Stimulant Use Disorder

Deep TMS of Neural Circuits Associated With Stimulant Use Disorder

Condition
Methamphetamine Use Disorder
Intervention / Treatment

-

Contacts and Locations

Palo Alto

VA Palo Alto Health Care System, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Transcranial magnetic stimulation (TMS) and magnetic resonance imaging (MRI) contraindications: such as a cardiac pacemaker, cochlear implant, or an implanted device (deep brain stimulation, ferromagnetic metal in the head and body, claustrophobia, pregnant or breastfeeding or other ferromagnetic device/object in the head and body within 30 cm of the treatment coil.
  • * General medical condition, disease, or neurological disorder that interferes with the assessments or participation.
  • * Unable to safely withdraw, at least two weeks prior to treatment, from medications that increase seizure risk.
  • * Current substance abuse as determined by positive toxicology screen
  • * Have a mass lesion, cerebral infarct, or other active CNS disease, including a seizure disorder.
  • * A recent suicide attempt (defined as within the last 30 days) or presence of current suicidal plan or intent. Patients at risk for suicide will be required to establish a written safety plan involving their primary therapist before entering the study.
  • * Severe impediment to vision, hearing and/or hand movement, as this is likely to interfere with the ability to follow study protocols.
  • * Greater than mild traumatic brain injury (defined as greater than 10 minutes loss of consciousness).
  • * Taking benzodiazepines or neuroleptic medications, or any medication known to alter seizure threshold.
  • * Acute or unstable chronic illness.
  • * Current or lifetime history of bipolar disorder or psychosis.
  • * Participation in another concurrent intervention-based clinical trial.

Ages Eligible for Study

25 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Claudia B Padula, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Michelle R Madore, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2026-12-31